How it works
A GLP-1 receptor agonist studied for glucose-dependent signaling, gastric emptying, and central satiety pathways.

AGE VERIFICATION
CATALOG ITEM

Identifying details were hidden for privacy. The test results are shown as they appeared in the original report. For research use only.
A GLP-1 receptor agonist studied for glucose-dependent signaling, gastric emptying, and central satiety pathways.
Studied for obesity, overweight, type 2 diabetes, and cardiometabolic risk.
Glucose regulation, energy intake, satiety, and cardiometabolic markers.
A long-acting GLP-1 agonist, built for weekly rather than daily dosing.